immunodiagnostic (elisa) kits for over 20 infectious diseases including giardia, cryptosporidium and dengue. ivd research carries a wide range of serum antibody and stool antigen detection assays. our elisa kits are available worldwide.
copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
In vitro diagnostics - Global In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections In vitro simply means ‘in glass’, meaning these tests are typically conducted in test tubes and similar equipment, as opposed to in vivo tests, which are conducted in the body itself
In vitro diagnostics - World Health Organization (WHO) In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections In vitro simply means ‘in glass’, meaning these tests are typically conducted in test tubes and similar equipment, as opposed to in vivo tests, which are conducted in the body itself
Week of Quality for In Vitro Diagnostics 2025: Registration Now Open Join us for the WHO's Week of Quality for IVDs training program Register your interest to participate in this valuable training program IVD manufacturers and regulatory authorities (Ministry of Health, National Regulatory Authorities) in all WHO regions are welcome to attend
Call for experts: Strategic Advisory Group of Experts on In Vitro . . . SAGE IVD members are appointed for 2 years and can be reappointed once Functions of the Strategic Advisory Group of Experts on In Vitro DiagnosticsTo serve as a principal advisory group to the WHO Director-General on all aspects of IVDs
Health products policy and standards The World Health Organization (WHO) has established a Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD) to act as an advisory body on matters of global policies and strategies related to in vitro diagnostics (IVDs)
Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD) In 2018, the World Health Organization (WHO) established the Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD) to act as an advisory body to matters of global policies and strategies related to in vitro diagnostics (IVDs)
In vitro diagnostics for COVID-19 - World Health Organization (WHO) The EUL procedure is developed to expedite the availability of IVDs needed in public health emergency situations It is intended to assist interested procurement agencies and Member States on the suitability for use of a specific IVD, based on a minimum set of available quality, safety, and performance data
Specialized Technical Assistance - IVDs For some manufacturers, meeting requirements for WHO prequalification (PQ) or emergency use listing (EUL) can be challenging In addition, global initiatives to harmonize regulation of in vitro diagnostics (IVDs) and other medical devices have resulted in changed regulatory requirements at national, regional, and global levels, which may be difficult to interpret WHO provides specialized
WHO Information Notice for Users 2020 05 This notice supersedes WHO Information Notice for In Vitro Diagnostic Medical Device (IVD) Users 2020 05 version 1, issued 14 December 2020 Description of the problem: WHO requests users to follow the instructions for use (IFU) when interpreting results for specimens tested using PCR methodology